<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Surface-modified yeast cells: a novel eukaryotic carrier for oral application</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Elisabeth</forename><forename type="middle">E</forename><surname>Kenngott</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Molecular and Cell Biology</orgName>
								<orgName type="institution">Saarland University</orgName>
								<address>
									<postCode>D-66123</postCode>
									<settlement>Saarbrücken</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">Charité Universitätsmedizin Berlin and Deutsches Rheuma-Forschungszentrum</orgName>
								<address>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ruth</forename><surname>Kiefer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Molecular and Cell Biology</orgName>
								<orgName type="institution">Saarland University</orgName>
								<address>
									<postCode>D-66123</postCode>
									<settlement>Saarbrücken</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicole</forename><surname>Schneider-Daum</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Drug Delivery</orgName>
								<orgName type="institution" key="instit1">Helmholtz-Institute for Pharmaceutical Research Saarland</orgName>
								<orgName type="institution" key="instit2">Saarland University</orgName>
								<address>
									<postCode>D-66123</postCode>
									<settlement>Saarbrücken</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alf</forename><surname>Hamann</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Charité Universitätsmedizin Berlin and Deutsches Rheuma-Forschungszentrum</orgName>
								<address>
									<postCode>D-10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marc</forename><surname>Schneider</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Pharmacy, Biopharmaceutics and Pharmaceutical Technology</orgName>
								<orgName type="institution">Saarland University</orgName>
								<address>
									<postCode>D-66123</postCode>
									<settlement>Saarbrücken</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Manfred</forename><forename type="middle">J</forename><surname>Schmitt</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Molecular and Cell Biology</orgName>
								<orgName type="institution">Saarland University</orgName>
								<address>
									<postCode>D-66123</postCode>
									<settlement>Saarbrücken</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Frank</forename><surname>Breinig</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Molecular and Cell Biology</orgName>
								<orgName type="institution">Saarland University</orgName>
								<address>
									<postCode>D-66123</postCode>
									<settlement>Saarbrücken</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Molecular and Cell Biology</orgName>
								<orgName type="institution">Saarland University</orgName>
								<address>
									<addrLine>Building A1.5</addrLine>
									<postCode>D-66123</postCode>
									<settlement>Saarbrücken</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Surface-modified yeast cells: a novel eukaryotic carrier for oral application</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">43648D30A2BDD5F280860472AE496F79</idno>
					<idno type="DOI">10.1016/j.jconrel.2015.12.054</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:47+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Oral delivery</term>
					<term>Saccharomyces cerevisiae</term>
					<term>cell surface-expression</term>
					<term>invasin</term>
					<term>M cell</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The effective targeting and subsequent binding of particulate carriers to M cells in Peyer´s patches of the gut is a prerequisite for the development of oral delivery systems.</s><s>We have established a novel carrier system based on cell surface expression of the β1-integrin binding domain of invasins derived from Yersinia enterocolitica and Y. pseudotuberculosis on the yeast Saccharomyces cerevisiae.</s><s>All invasin derivatives were shown to be effectively expressed on the cell surface and recombinant yeast cells showed improved binding to both human HEp-2 cells and M-like cells in vitro.</s><s>Among the different derivatives tested, the integrin-binding domain of Y. enterocolitica invasin proved to be the most effective and was able to target Peyer´s patches in vivo.</s><s>In conclusion, cell surface-modified yeasts might provide a novel bioadhesive, eukaryotic carrier system for efficient and targeted delivery of either antigens or drugs via the oral route.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Vaccination is one of the most successful and important means of modern medicine leading to a significant decrease of mortality caused by a number of infectious microbes in the last decades.</s><s>However, due to an increasing resistance of known pathogenic microorganisms as well as the appearence of new pathogens, there is still a need for the development of novel vaccines.</s><s>Most human pathogens like bacteria and viruses enter the body via the mucosal surfaces of the gastrointestinal and respiratory tracts.</s><s>Therefore, newly developed vaccines should be able, beyond the induction of a protective cellular and humoral immune response, to provoke also a mucosa-associated immune response resulting in the production of IgA by the mucosal surfaces.</s><s>The immunologically active sites in the gastrointestinal mucosa are called gut-associated lymphoid tissue (GALT), and contain organized lymphoid follicles (Peyer´s patches, PP) <ref type="bibr" target="#b0">[1]</ref>.</s><s>A common feature of PP includes an epithelial surface containing M cells which are involved in luminal uptake, transport, and processing of mucosally introduced antigens.</s><s>Following the uptake via M cells, the particular antigen is transported to immune cells such as T and B lymphocytes, dendritic cells, and macrophages which are located beneath the surface of the PP in order to finally induce an effective immune response <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>.</s><s>Characteristically, M cell-mediated antigen uptake is associated with the development of an secretoric IgA (sIgA) response <ref type="bibr" target="#b3">[4]</ref>.</s><s>A strong mucosal immune response is able to prevent the infectious agent from attaching and colonising the mucosal epithelium (non-invasive bacteria) or from penetrating and replicating in the mucosa (viruses and invasive bacteria).</s><s>It can also block microbial toxins from binding to and affecting epithelial and other target cells.</s></p><p><s>However, only a few of today´s vaccines are applied via the mucosal route.</s><s>Most of the currently available vaccines are licensed for use only via a nonmucosal route, usually subcutaneous or intramuscular inoculation <ref type="bibr" target="#b4">[5]</ref>.</s><s>One of the most critical factors for the induction of protective mucosal immune responses represents the effective adhesion of the antigens to the mucosal surface and, in particular, the embedded M cells <ref type="bibr" target="#b1">[2]</ref>.</s><s>Some pathogenic organisms, including Yersinia, have developed a mechanism to specifically exploit M cells in order to invade the body.</s><s>These pathogens express specialized surface proteins, so called invasins, that can bind to surface receptors on mammalian cells and lead to an enhanced uptake of Yersinia by these cells <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>.</s><s>The invasin from Yersinia pseudotuberculosis represents a 986 amino acid protein of the outer membrane <ref type="bibr" target="#b7">[8]</ref>.</s><s>The carboxy terminal 192 amino acids of this protein bind to some of the members of the β1-integrin superfamily, while the remainder of the protein is responsible for the presentation of the binding domain on the cell surface <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s><s>Y. enterocolitica possesses a homologue invasin but both proteins are not identical <ref type="bibr" target="#b10">[11]</ref>.</s></p><p><s>With respect to the integrin receptors, it shows the same binding behavior as pseudotuberculosis invasin <ref type="bibr" target="#b11">[12]</ref>.</s><s>Similar to the invasin of Y. pseudotuberculosis, the integrin-binding domain is located in the C-terminal region of the protein <ref type="bibr" target="#b13">[13]</ref>.</s><s>In line with this, Critchley-Thorne et al. <ref type="bibr">(2006)</ref> showed in a mouse model that expression of invasin from Y. pseudotuberculosis on non-pathogenic Escherichia coli cells leads to uptake of these bacteria by M cells in the Peyer's patches <ref type="bibr" target="#b14">[14]</ref>.</s><s>Likewise, expression of Y. pseudotuberculosis invasin on the surface of Salmonella typhimurium resulted in increased translocation of the recombinant bacteria from the intestinal lumen into the mesenteric lymph nodes <ref type="bibr" target="#b15">[15]</ref>.</s><s>Further, invasin-coated particles were successfully used for targeting to different cell lines, suggesting a high potential of such adhesins with regard to the development of novel, so called bioadhesive carriers <ref type="bibr" target="#b16">[16]</ref>.</s></p><p><s>In the last years, we and other groups described the successful usage of intact, recombinant yeast cells for the delivery of both proteins <ref type="bibr" target="#b17">[17]</ref><ref type="bibr" target="#b19">[18]</ref><ref type="bibr" target="#b20">[19]</ref><ref type="bibr" target="#b21">[20]</ref><ref type="bibr" target="#b22">[21]</ref><ref type="bibr" target="#b23">[22]</ref> and functional nucleic acids <ref type="bibr" target="#b24">[23]</ref><ref type="bibr" target="#b25">[24]</ref><ref type="bibr" target="#b26">[25]</ref><ref type="bibr" target="#b27">[26]</ref><ref type="bibr" target="#b28">[27]</ref><ref type="bibr" target="#b29">[28]</ref> indicating the potential of yeast cells for the development of novel vaccines.</s><s>Here, we report the construction of a novel, bioadhesive delivery system 5 based on the surface-expression of the integrin binding domains of Y. enterocolitica or Y. pseudotuberculosis invasin on the baker´s yeast Saccharomyces cerevisiae.</s><s>The recombinant yeast cells showed a significant binding to human epithelial cells and M cells in vitro as well as Peyer´s patches in vivo, rising the possibility to use the surfacemodified yeast cells as carrier for efficient oral delivery of either antigens or drugs in the human gut.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Strains, culture media and methods</head><p><s>Standard molecular manipulations were performed as described <ref type="bibr" target="#b30">[29]</ref>.</s><s>For cloning, E. coli strain TOP10 (F -mcrA ∆(mrr-hsdRMS-mrcBC) Φ80lacZM15 ∆lacX74 recA1 deoR araD139 ∆(ara-leu)7697 galU galK rspL (Str R ) endA1 nupG) was grown at 37°C in LB-medium supplemented with 100 µg ampicillin ml -1 when necessary.</s><s>For the in vivo expression of all constructed fusion proteins, S. cerevisiae strain EBY100 (MATa ura 3-52 trp 1 leu2∆1 his3∆200 pep4:HIS3 prb1∆1.6R</s><s>can1 GAL; strain includes AGA1 gene under control of a GAL promotor and URA3 as selection marker; Invitrogen) was used.</s><s>Cells were grown in YEPD medium at 30°C.</s><s>Transformation was carried out by the lithium acetate method according to Ito et al. <ref type="bibr" target="#b31">[30]</ref> and transformants were selected on trp d/o medium.</s><s>To express the fusion proteins, cells were grown in YNB-CAA medium containing glucose overnight and were then switched to galactose-containing YNB-CAA.</s><s>PCR amplifications were performed using high fidelity Taq DNApolymerase (Roche) according to the instructions of the manufacturer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Construction of cell wall fusion proteins</head><p><s>The genes encoding the extracellular part of invasin of Y. enterocolitica or</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Indirect immunofluorescence</head><p><s>Indirect immunofluorescence was performed with a monoclonal Anti-Xpress Antibody (Invitrogen) according to the manufacturer specifications.</s><s>In brief, exponentially growing yeast cells were harvested, washed with PBS (pH 7.4) and incubated with anti-Xpress antibody diluted 1/100 in PBS for one hour at room temperature with occasional mixing.</s><s>Subsequently, the cells were washed three times with PBS and incubated with a fluoresceine isothiocyanate (FITC)-labeled anti-mouse-IgG (Roche)</s></p><p><s>for one hour at room temperature in the dark.</s><s>After washing, cells were examined on a fluorescence microscope (Biozerø; KEYENCE) using 488 nm as excitation wavelength.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell culture</head><p><s>The human adherent epithelial cell lines HEp-2 and Caco-2 were cultured in Dulbecco's modified Eagle medium (DMEM; Sigma) supplemented with 10 % fetal calf serum (FCS; Biochrom), penicillin (50 U ml -1 ) and streptomycin (50 µg ml -1 ; Biochrom).</s></p><p><s>The suspension cell line Raji was cultured in RPMI 1640 (Sigma) supplemented with 10 % fetal calf serum (FCS), penicillin (50 U ml -1 ) and streptomycin (50 µg ml -1 ).</s><s>Cells were grown in a humidified 5 % CO2 atmosphere at 37°C.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vitro infection of HEp-2 monolayers with yeast cells</head><p><s>Yeast cells induced in YNB-CAA medium containing galactose were harvested by centrifugation, washed three times with sterile PBS, counted and resuspended in cell culture medium.</s><s>In preparation for either assay, HEp-2 cells were released with trypsin/EDTA (Sigma) for some minutes at 37°C and replaced into a 24-well plate, and grown to nearly confluency.</s><s>Subsequently, 5 x 10 6 yeast cells per well were added;</s></p><p><s>after an incubation step of 3 hours at 37°C and 5 % CO2 the cultures were carefully washed several times with cell culture medium to remove unbound yeast cells.</s></p><p><s>Subsequently, human cells were lysed by the addition of 0.1 % Triton X-100 and the remaining yeast cells were harvested by centrifugation.</s><s>The number of bound yeast cells was enumerated by plating appropriate dilutions on YEPD agar and incubation at 30°C.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vitro M cell model</head><p><s>M-like cells were generated as described <ref type="bibr" target="#b32">[31,</ref><ref type="bibr" target="#b33">32]</ref>.</s><s>In brief, Caco-2 were seeded onto porous membranes in Transwell plates (Corning; 1.12 cm 2 , pore size: 3 µm) and incubated at 37°C and 5 % CO2 to a confluency of at least 80 % in order to allow full differentiation before addition of 1.8 x 10 5 Raji B cells in the basal chamber.</s><s>The cocultures were incubated for further 5 days in a medium consisting of 1/3 RPMI and 2/3 DMEM.</s><s>Morphological changes after co-culture were checked microscopically using Phalloidin-TRITC staining <ref type="bibr" target="#b33">[32]</ref>.</s><s>The Caco-2 monolayer was washed once with PBS and fixed with 3.7 % formaldehyde for 30 min.</s><s>After two more washing steps, 1.8 x 10 6 yeast cells were added to the apical chamber in a volume of 500 µl and the basal chamber was filled with 1.5 ml fresh medium.</s><s>Following an incubation of two hours at 37°C and 5 % CO2, the Caco-2 monolayer was carefully washed three times with PBS to eliminate unbound yeast cells.</s><s>Eventually, the mammalian cells were lysed by adding 0.1 % Triton X-100 and the remaining yeast cells were plated in different dilutions on YEPD agar.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assessment of cell monolayer integrity and morphological as well as functional changes in co-cultures</head><p><s>Cell monolayer integrity and morphological changes during co-culture were assessed by labeling F-actin with TRITC-Phalloidin (Life Technologies) and subsequent microscopical analysis.</s><s>Monolayers were washed with HBSS buffer and fixed by incubation with 3.7 % formaldehyde for 10 minutes.</s><s>After two washing steps with HBSS, cells were first incubated for 10 minutes with 0.1 % TritonX 100 (Sigma) at room temperature, washed again and incubated for 1 hour with TRITC-Phalloidin in PBS (1 µg/ml).</s><s>After extensive washing, the filter membrane was removed, placed on a glass slide and immediately analyzed by laser scanning microscopy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell monolayer integrity was analyzed by measurement of the Trans-Epithelial</head><p><s>Electrical Resistance (TEER).</s><s>Monolayers were gently washed with pre-warmed HBSS and measured at 37°C using an Ag/AgCl electrode.</s><s>TEER values are depicted in unit area resistance (Ω cm 2 ) = resistance (Ω) x effective membrane area (cm 2 ).</s></p><p><s>To detect functional changes in mono-versus co-cultures, transport efficiency of monolayers was analyzed using fluorescent microspheres.</s><s>Fluoresbrite® Microparticles (0,46 µm; Polysciences, Inc.) diluted in cell culture medium were introduced into the apical chamber of transwells.</s><s>The basolateral solution was sampled at several time points and analyzed using an ELISA reader.</s><s>Percentage of translocation was calculated using the donor solution for calibration.</s><s>After incubating the co-culture in the microsphere solution for 250 minutes, monolayers were analyzed microscopically as described earlier.</s></p><p><s>10</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>In vivo visualisation of yeast cell uptake</head><p><s>For in vivo analysis of yeast cell uptake in intestinal mucosa, yeast cells were labeled with 5-( <ref type="formula">6</ref> Prior to confocal microscopy the sections were warmed up to room temperature and mounted with DAKO mounting medium containing DAPI (Sigma).</s><s>Slides were analyzed with a LSM 710 confocal microscope (Zeiss) and pictures were taken using the software Zen 2011 (Zeiss).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Construction of invasin fusion proteins and targeting to the cell wall</head><p><s>In order to develop a yeast-based carrier for oral application we used the wellestablished Aga1/Aga2 system in which the protein of interest is fused to Aga2 and subsequently anchored via Aga1 to the yeast cell surface (Fig. <ref type="figure">1A</ref>; <ref type="bibr" target="#b34">[33]</ref>).</s><s>We  After GAL1-induced expression, localization of the respective cell wall fusion was investigated by indirect immunofluorescence probed with antibodies against the incorporated Xpress tag (as the correct invasin specific antibodies were not available in our lab).</s><s>As expected, all yeast transformants showed a bright fluorescence that was localized over the entire cell wall whereas control cells showed no fluorescence (Fig. <ref type="figure">2A</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Figure 2:</head><p><s>The Aga2/invasin fusions are located at the yeast cell surface.</s><s>S. cerevisiae strain EBY100 was transformed with the respective invasin derivative and expression of the cell wall fusion protein was investigated using indirect immunofluorescence.</s></p><p><s>Exponential growing yeast cells were stained with a monoclonal anti-X-press-antibody followed by treatment with a FITC-labeled secondary antibody.</s><s>A nomarsky image as well as the corresponding fluorescence image are shown.</s></p><p><s>However, as the Xpress tag is also present in the empty control vector, a simple detection of fluorescence is not a direct proof for a successful expression of the invasin 14 fusions.</s><s>Therefore, we performed a Western Blot with cell wall extracts after DTTtreatment yielding specific signals and demonstrating that the Aga2/invasin derivatives were successfully targeted to the yeast cell wall (not shown).</s><s>Subsequent FACS analysis revealed that about 56 % of the control cells (empty vector) expressed Aga2 whereas expression rates of the invasin derivatives were slightly lower with 35 % (Y.ent397) and 39 % (Y.ent198) for Y.ent, and 44 % (Y.pst497) and 42 % (Y.pst197) for Y.pst, respectively.</s><s>This confirms results from Moelleken and Hegemann who expressed the adhesion domain Y. pseudotuberculosis invasin on S. cerevisiae using the same anchoring system <ref type="bibr" target="#b36">[35]</ref>.</s><s>Taken together, our results show that the different invasin derivatives can be successfully targeted in roughly equal amounts to the cell wall of S. cerevisiae.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell wall-anchored invasin derivatives differ in their ability to bind to human HEp-2 cells</head><p><s>As invasin is known to interact with β1-integrins on the surface of human cells <ref type="bibr" target="#b6">[7]</ref> we tested whether the different invasin derivatives mediate a binding of the recombinant yeast cells to HEp-2 cells.</s><s>To do so, we incubated yeast cells expressing the different invasin variants with HEp-2 cells seeded in well plates and determined the amount of bound yeast cells.</s><s>In contrast to yeast cells expressing Aga2 alone, yeast cells presenting invasin on their surface showed a significant affinity for HEp-2 cells (Fig. <ref type="figure" target="#fig_3">3</ref>; p&lt;0.05 for all invasin derivatives).</s><s>In particular, although not entirely statistically significant (p=0.07),</s><s>Y.ent mediated a considerably higher binding to HEp-2 cells than Y.pst.</s><s>Regarding the length of the invasin domains there was a significant higher binding of the shorter derivatives containing only the actual adhesion domain (Y.ent198 and Y.pst197; p&lt;0.05 each).</s><s>Considering the fact that Y.ent is slightly less expressed than Y.pst (see above), these specific differences clearly argue for an invasin-dependent interaction of the surface-modified yeast cells with ligands on the surface of HEp-2 cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Surface-modified yeast cells bind to M-like cells</head><p><s>Adhesion of a particular carrier to M cells within the mucosal surfaces of the gut is one of the most promising strategies for the induction of mucosal immune responses <ref type="bibr" target="#b4">[5]</ref>.</s></p><p><s>Consequently, after having established the yeast-based display system for invasin, we 16 next asked whether the recombinant yeast cells are also able to mediate a binding to in vitro generated M-like cells.</s><s>In order to investigate this we used a well-established system in which the co-culturing of human intestinal epithelial Caco-2 cells and Raji B cells leads to the differentiation of a subpopulation of epithelial cells into M-like cells (Fig. <ref type="figure" target="#fig_4">4A</ref>; <ref type="bibr" target="#b32">[31,</ref><ref type="bibr" target="#b33">32]</ref>).</s><s>For these experiments we used only the short invasin variants that showed the highest binding in the HEp-2 system (Y.ent198 and Y.pst197; see above).</s></p><p><s>After incubation with the respective yeast transformants, the number of yeast cells bound to the co-cultured Caco-2/Raji B cells was determined and compared to the amount of cells bound to a standard Caco-2 monolayer (Fig. <ref type="figure" target="#fig_4">4B</ref>).</s><s>Morphological and functional changes resulting from the co-culture were routinely checked by measuring TEER-values, translocation efficiency of fluorescent microparticles, and also by Factin/Phalloidin staining (see suppl.</s><s>Fig. <ref type="figure">1</ref>).</s><s>In particular, the invasin-expressing yeast cells showed a significant higher affinity to the co-cultured cells than to Caco-2 cells alone (Y.ent198: p&lt;0.01;</s><s>Y.pst197: p&lt;0.05).</s></p><p><s>Interestingly, also the binding of the control cells expressing Aga2 only was significantly increased (p&lt;0.05),</s><s>clearly indicating that the co-culture of Caco-2 and Raji B cells leads to specific changes in the Caco-2 monolayer as orginally described for the in vitro M cell model <ref type="bibr" target="#b32">[31,</ref><ref type="bibr" target="#b33">32]</ref>.</s><s>However, both invasin-displaying yeast transformants showed a significant higher binding than the control cells (p&lt;0.05 each), suggesting that the binding is mediated by an interaction of the invasin adhesion domains to specific ligands at the surface of the human cells.</s><s>Again, and in agreement with the data derived from the HEp-2 model (see above), expression of Y.ent proved to be more effective in comparison to the Y.pst invasin (Fig. <ref type="figure" target="#fig_4">4</ref>).</s><s>Taken together, these results</s></p><p><s>clearly account for an invasin-dependent binding of the surface-modified yeast cells to human M-like cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Surface-expression of Y.ent198 increases targeting to the small intestine in vivo</head><p><s>To test whether surface modification of yeast actually leads to an increased uptake via the intestinal mucosa in vivo we fed mice with fluorecently labeled yeast cells expressing Y.ent198 as this derivative yielded the best in vitro binding.</s><s>Four hours after treatment, mice were sacrificed and the transport of yeast cells into the tissue of the jejunum was analyzed microscopically.</s><s>In none of the analyzed samples yeast cell uptake within in the villous region of the small intestine was observed.</s><s>In contrast, the CFSE-labeled yeast cells detected in these sections were restricted to the gut lumen (Figure <ref type="figure">5</ref>, top row).</s><s>As already shown in the literature, isolated signals were observed within PP of mice fed with control yeast 5, center) showing that yeast cells can principally be taken up into lymphoid structures in the small intestine <ref type="bibr" target="#b37">[36]</ref>.</s><s>However, the uptake in PP tissue was highly increased in animals treated with Y.ent198expressing yeast cells (Figure <ref type="figure">5</ref>  Yeast cells are naturally able to fulfil the qualifications for such a carrier in a unique manner: yeast per se is particulate with a size of a few micrometers, protects a foreign antigen from degradation during the stomach passage by acidic pH or by proteases in the gut and remains viable in the intestine for up to a week <ref type="bibr" target="#b41">[40]</ref>.</s><s>It is taken up by M cells <ref type="bibr" target="#b37">[36]</ref> and is known to possess adjuvant effects by stimulating innate immune responses by structural cell wall components <ref type="bibr" target="#b21">[20,</ref><ref type="bibr" target="#b42">41,</ref><ref type="bibr" target="#b43">42]</ref>.</s><s>In particular, yeast is able to stimulate TLR2 and 4 which have been shown to enhance microparticle uptake by M cells and to support mucosal adjuvantic properties of a carrier <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b44">43,</ref><ref type="bibr" target="#b45">44]</ref>.</s><s>Moreover, it has been shown to generate adaptive (including cell-mediated) immune responses in mice after subcutaneous or oral application <ref type="bibr" target="#b20">[19,</ref><ref type="bibr" target="#b46">[45]</ref><ref type="bibr" target="#b48">[46]</ref><ref type="bibr" target="#b49">[47]</ref> and also in humans <ref type="bibr" target="#b50">[48]</ref>.</s></p><p><s>Importantly, the potential of yeast as novel life vaccine reaches far beyond the criteria mentioned above: in contrast to the majority of attenuated bacteria and mammalian viruses (which are already under investigation as mucosal vaccine candidates, e.g.</s></p><p><s>Listeria) several yeast genera possess the GRAS (generally regarded as safe) status which should facilitate the approval of a yeast-based vaccine considerably.</s></p><p><s>Additionally, yeast combines the advantages of a single-cell microorganism (small size, easy cultivation, rapid cell growth) with the advantages of a eukaryotic cell (ability to perform complex posttranslational modifications, lack of endotoxins).</s><s>Further, many yeast genera are, due to the tremendous experience in using yeast in genetics and biotechnology for many years, also accessible to several genetical and structural modifications allowing amongst others the development of multivalent vaccines or the modulation of immune responses induced <ref type="bibr" target="#b21">[20,</ref><ref type="bibr" target="#b22">21]</ref>.</s><s>Eventually, almost essential for the usage in developing countries, they can be easily stored as dry-yeasts making a coldchain fully dispensable.</s></p><p><s>In order to enhance the natural features of a yeast-based carrier for a targeted delivery of antigens or drugs via M cells, we expressed different derivatives of invasins derived from Y. pseudotuberculosis and Y. enterocolitica on the cell surface of the baker's yeast S. cerevisiae using the well-established Aga1/Aga2 expression system <ref type="bibr" target="#b34">[33]</ref>.</s><s>In this system, the Aga2-invasin fusions are linked via disulfide-bonds to the cell wallanchored Aga1 moiety.</s><s>Every invasin derivative was successfully targeted to the cell wall and could be released by cleavage of the disulfide-bond after DTT-treatment (not shown).</s><s>All invasin-expressing yeast recombinants bound to human HEp-2 cells (Fig. <ref type="figure" target="#fig_3">3</ref>) demonstrating that the invasin binding domain on their cell surface is fully functional.</s></p><p><s>These results confirm data from Moelleken and Hegemann who expressed the binding domain of Y. pseudotuberculosis invasin in yeast using the same anchoring system and also found an enhanced binding of the surface-modified yeast cells to HEp-2 cells <ref type="bibr" target="#b36">[35]</ref>.</s><s>The shorter invasin constructs which contain only the adhesin domains (Y.ent198 and Y.pst197) as well as the elongated constructs with additional invasin domains (Y.ent397 and Y.pst497) were detected in roughly equal amounts on the cell surface.</s></p><p><s>Therefore, the observation of the increased binding ability of the shorter derivatives does not rely on different expression levels of the constructs.</s><s>In contrast, the most abundant fusion (Y.pst497) showed the weakest binding to HEp-2 cells.</s><s>However, the diminished binding of the longer fusions in general might be due to a steric interference of these additional domains with the binding to the integrin receptor.</s><s>Among both shortened invasin fusions, the binding mediated by Y.ent198 was considerably increased in comparison to Y.pst197.</s><s>These results were also confirmed using an in vitro M cell model to simulate the conditions in the intestinal tract (Fig. <ref type="figure" target="#fig_4">4</ref>).</s><s>Here, we investigated the shortened invasin fusions as they exhibited the strongest binding to the HEp-2 cells.</s><s>The yeasts were added to monolayers that were cultured either under monoculture (Caco-2) or co-culture conditions (Caco-2/Raji B cells), the latter leading to the differentiation of a subpopulation of the Caco-2 cells into M-like cells accompanied by a decrease in TEER-value and enhanced translocation efficiency of fluorescent particles <ref type="bibr" target="#b32">[31,</ref><ref type="bibr" target="#b33">32]</ref>.</s><s>Furthermore the three-fold increase in binding of the control cells without invasin demonstrates that the co-culture actually causes a change in the Caco-2 monolayers.</s><s>However, this improvement became even more apparent, and statistically significant, for the invasin-expressing yeast cells.</s><s>As already seen in the HEp-2 system, yeast cells expressing Y.ent198 on their surface showed the strongest binding; by co-culture of Caco-2 cells with B cells, the binding of these cells was increased more than twenty times.</s><s>Importantly, the recombinant cells expressing Y.ent198 are able to target PP as well as the overlying M cells also in vivo.</s><s>After feeding of mice with fluorescent labeled yeast cells it was shown via fluorescence microscopy that Y.ent198 expressing yeast were considerably more effectively taken up in PP tissue than the respective control yeast.</s></p><p><s>The results of this study confirm that the binding properties of recombinant yeast can be improved with regard to their oral administration.</s><s>In particular, the expression of the integrin-binding domain of the Y. enterocolitica invasin significantly increased the binding to human epithelial cells in two different in vitro model systems and also in vivo.</s></p><p><s>Our data implicate that invasin-expressing yeast cells can be used to target M cells specifically in vivo and lay the basics for the development of a novel yeast-based carrier for antigens or drugs.</s><s>In future studies, the invasin-expressing yeast cells will be tested for their ability of delivering a model antigen to immune cells after oral application and to subsequently induce an antigen-specific immune response.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Y</head><label></label><figDesc><div><p><s>. pseudotuberculosis were optimised for codon usage of S. cerevisiae by the synthesis of an artificial gene sequence (GeneArt, Regensburg) encoding the Cterminal 397 amino acids (aa; Y. enterocolitica) and 497 aa (Y.</s><s>pseudotuberculosis) of the natural invasin protein.</s><s>For cloning, EcoRI and NotI restriction sites were introduced.</s><s>The shortened invasin variants (198 aa in case of Y. enterocolitica and 197 aa for Y. pseudotuberculosis, respectively) were PCR-amplified using the particular artificial gene sequence as template and the following primers: 5' Y.entInv BD EcoRI (5'-GAATTCATCACCTTGTACCCAATTCCAAAGATTACCTC-3'), 3' Y.entInv BD NotI and 3' Y.pstInv BD NotI (5'-GCGGCCGCTCATCAGATGGAC-3').</s><s>Invasin derivatives were then inserted in the pYD1 expression vector (Invitrogen) via EcoRI/NotI restriction, yielding the plasmids pYD1-Y.ent397,</s><s>pYD1-Y.pst497,</s><s>pYD1-Y.ent198,</s><s>and pYD1-Y.pst197</s><s>(see Fig.1).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>constructed fusion proteins consisting of Aga2 and the invasins of Y. pseudotuberculosis (Y.pst) and Y. enterocolitica (Y.ent) in two different lengths corresponding to the complete extracellular invasin domains (Y.pst497 and Y.ent397) or the adhesion domains alone (Y.pst197 and Y.ent198), respectively (Fig.1B;<ref type="bibr" target="#b35">[34]</ref>).</s><s>In order to ensure proper translation the invasin sequences were codon-optimized for yeast.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 1 : 12 (</head><label>112</label><figDesc><div><p><s>Figure 1:</s></p></div></figDesc><graphic coords="12,70.56,380.16,384.00,363.84" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 :</head><label>3</label><figDesc><div><p><s>Figure 3:</s></p></div></figDesc><graphic coords="16,70.56,153.36,416.16,270.72" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 :</head><label>4</label><figDesc><div><p><s>Figure 4:</s></p></div></figDesc><graphic coords="18,70.56,199.20,422.16,385.68" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc><div><p><s>, bottom) with a scattering of the CFSE signal indicating a vesicular distribution within the PP cells confirming both a successful and effective targeting of the Y.ent198-expressing yeast cells to PP.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 5 : 20 Invasin</head><label>520</label><figDesc><div><p><s>Figure 5:</s></p></div></figDesc><graphic coords="20,70.56,374.16,408.48,365.76" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="1,15.00,16.20,565.28,141.22" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="14,70.56,201.12,373.92,261.12" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="32,80.64,175.80,434.16,315.48" type="vector_box" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>)-Carboxyflourescein diacetate N-succinimidylester (CFSE; Sigma).</s><s>For this purpose, lyophilized yeast cells were washed twice with PBS and resuspended in PBS containing 0.1% DMSO and 1µM CFSE.</s><s>After 90 minutes incubation, the cells were washed three times with PBS to remove remaining dye.</s><s>Female BALB/c mice were purchased from Charles River, housed in a specific pathogen free environment and used for experiments at 8-10 weeks of age.</s><s>All experiments were approved by the</s></p></div></figDesc><table /><note><p><s>Landesamt für Gesundheit und Soziales (LAGeSo; G 0014/14).</s><s>Mice were treated orally by gavage with 1 x 10 8 CFSE labeled yeast cells (negative control) or with Y.ent198 expressing yeast (n=3 for each group) resuspended in 200 µl PBS.</s><s>After four hours, mice were sacrificed by cervical dislocation and the small intestine was removed.</s><s>A 2-3 cm segment from the jejunum containing at least one PP was isolated, fixed for 16 hours in PBS containing 2 % PFA and dehydrated by incubation in solutions of increasing sucrose concentrations starting with 10 %, 20 % and finally 30 %, each for 8-16 hours at 4°C.</s><s>The tissue was embedded in Tissue-Tec O.T.C. cryo embedding medium (Sakura Finetec), frozen and 7 µm sections were cut using a HM 560 Cryotom (Thermo Fischer Scientific).</s><s>Sections were stored at -20°C.</s></p></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>The authors thank Isabel Martinez-Argudo and Marc Jepson for sharing the protocol for in vitro M-like cell differentiation.</s><s>This work was supported by an ESCMID research grant and a grant from Saarland Staatskanzlei (LFFP 1303) to FB.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Mucosal vaccines: the promise and the challenge</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Neutra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Kozlowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature reviews. Immunology</title>
		<imprint>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="148" to="158" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Mucosal vaccine design and delivery</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Woodrow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Lo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annual review of biomedical engineering</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="17" to="46" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">The role of M cells in the protection of mucosal membranes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gebert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histochem Cell Biol</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="455" to="470" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Kerneis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bogdanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-P</forename><surname>Kraehenbuhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pringault</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Conversion by Peyer´s patches lymphocytes of human enterocytes into M cells that transport bacteria</title>
				<imprint>
			<date type="published" when="1997">1997</date>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="949" to="952" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Novel vaccine development strategies for inducing mucosal immunity</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Fujkuyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tokuhara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kataoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Gilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mcghee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kiyono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fujihashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Rev Vaccines</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="367" to="379" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">A region of the Yersinia pseudotuberculosis invasin protein enhances integrin-mediated uptake into mammalian cells and promotes self-association</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dersch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Isberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1199" to="1213" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Integrin beta1-chain residues involved in substrate recognition and specificity of binding to invasin</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Krukonis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Isberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Microbiol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="219" to="230" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Isberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Voorhis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Falkow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="769" to="778" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Leong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Fournier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Isberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="1979" to="1989" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Invasin-dependent and invasin-independent pathways for translocation of Yersinia pseudotuberculosis across the Peyer&apos;s patch intestinal epithelium</title>
		<author>
			<persName><forename type="first">A</forename><surname>Marra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Isberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="3412" to="3421" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The invasin protein of Yersinia enterocolitica: internalization of invasin-bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">B</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Falkow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Schoolnik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biol</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="197" to="207" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">R</forename><surname>Schulte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kerneis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Klinke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bartels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Preger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Kraehenbuhl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pringault</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Translocation of Yersinia entrocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on Mlike cells</title>
		<author>
			<persName><surname>Autenrieth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Microbiol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="173" to="185" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Yersinia enterocolitica invasin: a primary role in the initiation of infection</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Pepe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Miller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="6473" to="6477" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Recombinant Escherichia coli expressing invasin targets the Peyer&apos;s patches: the basis for a bacterial formulation for oral vaccination, Molecular therapy : the journal of the American Society of Gene Therapy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Critchley-Thorne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Stagg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vassaux</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2006">2006</date>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="183" to="191" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Immunization with live aroA recombinant Salmonella typhimurium producing invasin inhibits intestinal translocation of Yersinia pseudotuberculosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Simonet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fortineau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Beretti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Berche</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="863" to="867" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Lectins and bacterial invasion factors for controlling endo-and transcytosis og bioadhesive drug carrier systems</title>
		<author>
			<persName><forename type="first">E</forename><surname>Haltner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Easson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-M</forename><surname>Lehr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Pharm</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="3" to="13" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Stubbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Coeshott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Skaates</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Kuritzkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bellgrau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Franzusoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Duke</surname></persName>
		</author>
		<author>
			<persName><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="625" to="629" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast</title>
		<author>
			<persName><forename type="first">F</forename><surname>Breinig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Heintel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schumacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Meyerhans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schmitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEMS Immunol Med Microbiol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="231" to="239" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Vaccines based on whole recombinant Saccharomyces cerevisiae cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ardiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Hodge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEMS Yeast Res</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1060" to="1069" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Heat treatment improves antigen-specific T cell activation after protein delivery by several but not all yeast genera</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Bazan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Breinig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breinig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="2591" to="2598" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Uptake of various yeast genera by antigen-presenting cells and influence of subcellular antigen localization on the activation of ovalbumin-specific CD8 T lymphocytes</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Bazan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Geginat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Breinig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breinig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="8165" to="8173" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Yeast-based protein delivery to mammalian phagocytic cells is increased by coexpression of bacterial listeriolysin</title>
		<author>
			<persName><forename type="first">B</forename><surname>Walch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Breinig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Geginat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breinig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Microbes Infect</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="908" to="913" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">mRNA delivery to human dendritic cells by recombinant yeast and activation of antigen-specific memory T cells</title>
		<author>
			<persName><forename type="first">F</forename><surname>Breinig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Breinig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schmitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Meth Mol Biol</title>
		<imprint>
			<biblScope unit="page" from="163" to="184" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Delivery of functional DNA and messenger RNA to mammalian phagocytic cells by recombinant yeast</title>
		<author>
			<persName><forename type="first">B</forename><surname>Walch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Breinig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breinig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="237" to="245" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Gene delivery to dendritic cells by orally administered recombinant Saccharomyces cerevisiae in mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Kiflmariam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="page" from="1360" to="1363" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">In vivo targeted delivery of CD40 shRNA to mouse intestinal dendritic cells by oral administration of recombinant Sacchromyces cerevisiae</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="709" to="714" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Schizosaccharomyces pombe: a novel transport vehicle of functional DNA and mRNA into mammalian antigen-presenting cells</title>
		<author>
			<persName><forename type="first">B</forename><surname>Walch-Rückheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breinig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="6029" to="6033" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Coexpression of human perforin improves yeast-mediated delivery of DNA and mRNA to mammalian antigenpresenting cells</title>
		<author>
			<persName><forename type="first">B</forename><surname>Walch-Rückheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kiefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Geginat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breinig</surname></persName>
		</author>
		<idno type="DOI">10.1038/gt.2015.77.29</idno>
	</analytic>
	<monogr>
		<title level="j">Gene Ther</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<monogr>
		<title level="m" type="main">Molecular cloning: a laboratory manual</title>
		<author>
			<persName><forename type="first">J</forename><surname>Sambrook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Fritsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Maniatis</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1989">1989</date>
			<publisher>Cold Spring Harbor Laboratory Press</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Transformation of intact yeast cells treated with alkali cations</title>
		<author>
			<persName><forename type="first">H</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Murata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kimura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Bacteriol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="163" to="168" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title level="m" type="main">Salmonella translocates across an in vitro M cell model independently of SPI-1 and SPI-2, Microbiology</title>
		<author>
			<persName><forename type="first">I</forename><surname>Martinez-Argudo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jepson</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2008">2008</date>
			<biblScope unit="volume">154</biblScope>
			<biblScope unit="page" from="3887" to="3894" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Identification of adhesin-receptor interactions driving bacterial translocation through M cells</title>
		<author>
			<persName><forename type="first">I</forename><surname>Martinez-Argudo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jepson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Fut microbiol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="549" to="553" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Yeast surface display for screening combinatorial polypeptide libraries</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Boder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Wittrup</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="553" to="557" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">A</forename><surname>Hamburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Isberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Bjorkman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Crystal structure of invasin: a bacterial integrin-binding protein</title>
				<imprint>
			<date type="published" when="1999">1999</date>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="page" from="291" to="295" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding</title>
		<author>
			<persName><forename type="first">K</forename><surname>Moelleken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Hegemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Microbiol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="403" to="419" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Kinetics of particle uptake in the domes of Peyer&apos;s patches</title>
		<author>
			<persName><forename type="first">R</forename><surname>Beier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gebert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="G130" to="137" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Oral vaccination in man using antigens in particles: current status</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Brayden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Pharm Sci</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="183" to="189" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Microparticle vaccine approaches to stimulate mucosal immunisation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Brayden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Baird</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Microbes Infect</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="867" to="876" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jepson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Hirst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Drug Deliv rev</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="511" to="525" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Treatment of persistent diarrhea with Saccharomyces boulardii. Results of a prospective investigation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kirchhelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Frühwein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tobüren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Fortschr Med</title>
		<imprint>
			<biblScope unit="page">114</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Characterization and optimization of the glucan particle-based vaccine platform</title>
		<author>
			<persName><forename type="first">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Ostroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Specht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Levitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Vac Immunol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="1585" to="1591" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists</title>
		<author>
			<persName><forename type="first">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Ostroff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Specht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Levitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Immun</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="1774" to="1781" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium</title>
		<author>
			<persName><forename type="first">S</forename><surname>Chabot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Farrant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Neutra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="4275" to="4283" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Cracking the Toll-like receptor code in fungal infections</title>
		<author>
			<persName><forename type="first">C</forename><surname>Cunha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Romani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Carvalho</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Exp rev anti-infective Ther</title>
				<imprint>
			<date type="published" when="2010">2010</date>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1121" to="1137" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">T</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Oral administration of myostatin-specific whole recombinant yeast Saccharomyces cerevisiae vaccine increases body weight and muscle composition in mice</title>
		<author>
			<persName><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="8412" to="8416" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Yeast-surface expressed BVDV E2 protein induces a Th1/Th2 response in naive T cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Patterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nerren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kogut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Court</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Villarreal-Ramos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Seyfert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dalby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Werling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Develop comp immunol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="107" to="114" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Oral immunization with whole yeast producing viral capsid antigen provokes a stronger humoral immune response than purified viral capsid antigen</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lett appl microbiol</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="285" to="291" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<monogr>
		<title level="m" type="main">Extensive MHC class I-restricted CD8</title>
		<author>
			<persName><forename type="first">T</forename><surname>Heintel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breinig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Meyerhans</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">T lymphocyte responses against various yeast genera in humans</title>
	</analytic>
	<monogr>
		<title level="j">FEMS Immunol Med Microbiol</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="279" to="286" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
